Once-Weekly TransCon™ CNP Achieved Primary Efficacy Objective, with Superiority at 100 µg/kg/week, in Ascendis Pharma’s Phase 2 ACcomplisH Trial of Children with Achondroplasia Aged 2 to 10 Years

Written by Customer Service on November 13, 2022. Posted in Public Companies.

– Data demonstrated that once-weekly TransCon CNP has the potential to meet patient and caregiver needs for a safe, effective, tolerable and convenient treatment – The primary endpoint, annualized height velocity (AHV) at Week 52, demonstrated superiority of TransCon CNP at 100 µg/kg/week compared to placebo (p=0.0218) – TransCon CNP was generally well tolerated with low frequency of injection site reactions; all 57 randomized children continued, with the longest treatment duration beyond two years – Data showed robust and consistent results in prespecified analyses across age groups and dose levels, supporting continued development at the selected dose of 100 µg/kg/week – Ascendis to host conference call and webcast Monday, November 14 at 8:00 a.m. Eastern time COPENHAGEN, Denmark, Nov. 14, 2022...

360 DigiTech Announces Third Quarter 2022 Unaudited Financial Results, Declares Quarterly Dividend and Announces Director Change

Written by Customer Service on November 13, 2022. Posted in Earnings Releases And Operating Results.

SHANGHAI, China, Nov. 13, 2022 (GLOBE NEWSWIRE) — 360 DigiTech, Inc. (QFIN) (“360 DigiTech” or the “Company”), a leading Credit-Tech platform in China, today announced its unaudited financial results for the third quarter ended September 30, 2022, declared quarterly dividend and announced director change. Third Quarter 2022 Business Highlights As of September 30, 2022, our platform has connected 141 financial institutional partners and 203.5 million consumers*1 with potential credit needs, cumulatively, an increase of 11.9% from 181.8 million a year ago. Cumulative users with approved credit lines*2 were 43.0 million as of September 30, 2022, an increase of 17.8% from 36.5 million as of September 30, 2021. Cumulative borrowers with successful drawdown, including repeat borrowers was 26.3 million as of September 30, 2022, an increase...

Global Tech Industries Group, Inc. Announces First Steps in Pursuing Dual Listing on the Upstream Platform

Written by Customer Service on November 13, 2022. Posted in Public Companies.

New York, NY, Nov. 13, 2022 (GLOBE NEWSWIRE) — (GTII: OTCQB) Global Tech Industries Group, Inc. (“GTII” or “The Company”), www.gtii-us.com, announced today that on November 12, 2022, at a special board of directors meeting, the directors of the Company authorized management to pursue a business relationship with Upstream, a global dual listing platform, up to and including the execution of a technology service agreement, a sponsor advisor agreement, as well as any other required documentation in furtherance of this goal, and report back to the board with a final recommendation. About Upstream: Powered by Horizon’s Ethereum-L2 matching engine technology, the platform enables users to trade NFTs, and invest in securities for IPOs, crowdfunded companies, U.S. & international equities, and celebrity ventures using the Upstream...

Sorrento to Host Webcast to Discuss Newly Presented Clinical Data Demonstrating Significant Improvements in Therapeutic Outcomes in 10 of 10 Patients with Poorly Controlled Rheumatoid Arthritis

Written by Customer Service on November 13, 2022. Posted in Public Companies.

ATLANTA and SAN DIEGO, Nov. 13, 2022 (GLOBE NEWSWIRE) — Sofusa®, a wholly-owned division of Sorrento Therapeutics (Nasdaq: SRNE, “Sorrento”), today announced that it will host a virtual Key Opinion Leader (KOL) panel discussion titled “Empowering the Lymphatics: Unleashing the Potential of Biologics that Target the Immune System” to be held on Thursday, November 17, 2022 at 11:30 AM EST. The event will feature a deep dive and discussion of the clinical study design and clinical data demonstrating improved therapeutic outcomes and lymphatic functioning in rheumatoid arthritis (RA) patients receiving the Sofusa Lymphatic Drug Delivery System (Sofusa) treatment. Patients who were enrolled in this study had inadequate response to the standard dose of an approved TNF inhibitor subcutaneous (SC) treatment, and 10 of 10 patients achieved...

Idorsia congratulates its Chief Scientific Officer Martine Clozel who has been honored by Initiative Switzerland with the Annual Prix Suisse Award

Written by Customer Service on November 13, 2022. Posted in Public Companies.

Martine Clozel was selected for the Prix Suisse award for her contribution to research, science, and medicine and was presented with the Prix Suisse by the National Council President Irène Kälin The Prix Suisse is an annual award presented by the non-profit organization Initiative Switzerland to individuals who have made outstanding contributions to Switzerland Allschwil, Switzerland – November 13, 2022Idorsia Ltd (SIX: IDIA) today announced that Chief Scientific Officer Martine Clozel was honored by the organization Initiative Switzerland with the annual Prix Suisse Award at an award ceremony in the Kursaal Bern on Saturday, 12 November. The Prix Suisse is a national award and represents the highest distinction for outstanding achievements in Switzerland and was presented to Martine by Irène Kälin, The President of the National Council...

ZeroFox to Showcase Unified Brand Protection at Black Hat Middle East and Africa

Written by Customer Service on November 13, 2022. Posted in Public Companies.

Company to exhibit at booth H4.C30C Nov. 15-17 in Saudi Arabia RIYDAH, Saudi Arabia, Nov. 13, 2022 (GLOBE NEWSWIRE) — ZeroFox (Nasdaq: ZFOX), a leading external cybersecurity provider, will exhibit at Black Hat Middle East and Africa (MEA), which runs Nov. 15-17 at Riyadh Front Exhibition Centre in Saudi Arabia. Conference attendees can visit with ZeroFox representatives who will be demonstrating the company’s recent product innovations in external cybersecurity at Booth H4.C30C. “In the Middle East and Africa, it is clear that businesses can benefit greatly from brand protection,” said ZeroFox Vice President of MEA/APAC Sales, Gabe Goldhirsh. “Companies in the MEA region need to secure their reputations and eliminate fraud from their digital presence. That’s where ZeroFox comes in. We find and take down external threats facing...

Avid Outlines Official Product Support and Self-Help Resources to Help Users Avoid Imposter Activity on Twitter

Written by Customer Service on November 13, 2022. Posted in Public Companies.

BURLINGTON, Mass., Nov. 12, 2022 (GLOBE NEWSWIRE) — Today Avid® (Nasdaq: AVID) issued a reminder for all customers around the world about every means by which they may easily obtain product support and self-help 24×7 through official Avid channels. In response to the emergence of illegitimate Twitter accounts impersonating many companies and other entities, Avid has provided this information proactively in order to assist those users who may typically rely upon Twitter to engage Avid’s support team. Join and participate in Avid’s online global user communities: Avid Pro Audio Community – duc.avid.com/ Avid Pro Video Community – community.avid.com/ Avid Sibelius Forum – www.sibelius.com/cgi-bin/helpcenter/chat/chat.pl?com=show&groupid=3 Engage through the Avid Link desktop app: Avid Link is automatically...

Day: November 13, 2022